The Annual Congress of International Drug Discovery Science &Technology (IDDST) initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan) and Amsterdam (the Netherlands) has attracted more than 10,000 participants from over 50 countries and regions in the previous 20 years. This year, the 21st Annual Congress of International Drug Discovery Science & Technology-2025 (IDDST-2025) will be held during May 12-14, 2025 at Kobe, Japan.
● Learn Global Market Trends for Drug Discovery
● Organize up to 150+ Oral Presentations on the Latest Trend
● 200+ Attendees to Exchange Ideas and Build New Networks
● Bring together 20+ Exhibitors and Posters on New Development
● Opportunities to Visit the local Natural and Cultural Landscapes
|
Dr. Matthias von Herrath, Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA |
|
 |
Dr. Boris Tankhilevich, CEO, Magtera, Inc., USA |
 |
Dr. Stefan J. Scherer, CEO and President, 3T Biosciences, USA |
 |
Ms. Chrissie Fletcher, Vice President of Biostatistics, GSK, UK |
 |
Dr. Parviz Ghahramani, CEO & Founder, Inncelerex, USA |
 |
Dr. Jeffrey M. Herz, President and CEO, Algomedix, Inc, USA |
 |
Dr. Rainer Ganschow, Director, Department of Pediatrics, University Children's Hospital Bonn, Germany |
 |
Dr. Nabil Hagag, Director of Cellular Therapies, Stony Brook Medicine, USA |
 |
Dr. Ottavio Arancio, Professor, Columbia University, USA |
 |
Dr. Bernard LA SCOLA, Professor, Aix-Marseille University, France |
 |
Dr. Yong Wang, Professor, The Pennsylvania State University, USA |
 |
Dr. Dongfeng Tan, Professor, Department of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, USA |
 |
Dr. Farzin Farzaneh, Chief Scientific Officer, Virocell Biologics Limited; Professor of Molecular Medicine, King’s College London, UK |
 |
Dr. Weiqiang Zhao, Professor of Pathology, The Ohio State University Wexner Medical Center, USA |
 |
Dr. Istvan J E Boksay, Clinical Professor of Psychiatry, Dementia Prevention Center, USA |
 |
Dr. Gyungah Jun, Associate Professor,Boston University, USA |
 |
Dr. Danilo A. Tagle, Director, National Institutes of Health, USA |
 |
Dr. Muhammad G Kibriya, Research Associate Professor, The University of Chicago, USA |
 |
Dr. Ali Ghodsi, Professor, University of Waterloo, Canada |
 |
Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
 |
Dr. Lixia Wang, SVP, Rigel Pharmaceuticals Inc., USA |
 |
Dr. Amitava Mukhopadhyay, Associate Director of Biostatistics, MorphoSys AG, Germany |
IDDST provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall
  |
Exhibition Date: |
Kobe is the capital of Hyogo Prefecture and one of Japan's ten largest cities. Located between the sea and the Rokko mountain range, Kobe is also considered one of Japan's most attractive cities. Its neighbouring city Osaka, and nearby Kyoto are the centres of the Keihanshin Industrial Zone, the second largest urban and industrial agglomeration in Japan, and the city and its surroundings constitute the western portion of the Osaka-Kobe metropolitan area.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
© 2003-2025 All rights reserved by BITeomics |
|